We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 1,423 results

  2. Hormonersatztherapie in den Wechseljahren

    Doris M. Gruber, Sophie K. Helwig in gynäkologie + geburtshilfe
    Article 19 October 2023

  3. Hormonersatztherapie in den Wechseljahren

    Doris M. Gruber in CME
    Article 19 June 2024

  4. Postmenopausale Hormonersatztherapie: Anleitung für die Praxis!

    Up to 85% of all peri- and postmenopausal women are affected by climacteric symptoms such as hot flashes, sleep disturbances, depressive mood...

    Elisabeth Lerchbaum in Journal für Klinische Endokrinologie und Stoffwechsel
    Article Open access 14 August 2023

  6. Hormonersatztherapie in der Peri- und Postmenopause und Krebsrisiko

    Hormone replacement therapy (HRT) in peri- and postmenopausal women is one of the most common endocrine interventions. HRT has a number of benefits...

    Olaf Ortmann in Die Gynäkologie
    Article 19 June 2024

  8. Hormonersatztherapie in den Wechseljahren – ist das noch State of the Art?

    Hormone replacement therapy (HRT) is a unique therapeutic option. It is however important to note that indication, duration, dosage, comorbidities,...

    Doris M. Gruber, Sophie K. Helwig in Journal für Gynäkologische Endokrinologie/Österreich
    Article 31 January 2023

  12. Zulassung für bioidentische Hormonersatztherapie

    Redaktion Facharztmagazine in gynäkologie + geburtshilfe
    Article 09 December 2021

  15. Einfluss einer Hormonersatztherapie in der Peri- und Postmenopause auf das Krebsrisiko

    Background

    Climacteric symptoms can significantly compromise the quality of life of women during peri- and postmenopause.

    Objective

    The effects of...

    Susanne Schüler-Toprak, Olaf Ortmann in Gynäkologische Endokrinologie
    Article 21 July 2022

  17. Differenzierter Einsatz von Gestagenen in der kombinierten Hormonersatztherapie – Einfluss auf das Mamma- und Endometriumkarzinomrisiko

    Progesterone and synthetic progestogenic compounds such as medroxyprogesterone acetate (MPA) are being used within the context of peri- and...

    Clemens Tempfer in Gynäkologische Endokrinologie
    Article 31 January 2022

  18. Hormonersatztherapie schützt auch Lungen

    Redaktion Facharztmagazine in gynäkologie + geburtshilfe
    Article 18 February 2021

  20. Hormonersatztherapie (HRT) in der Peri- und Postmenopause

    More than half of all peri- and postmenopausal women experience climacteric symptoms, most frequently vasomotor symptoms such as hot flashes. Hormone...

    Deborah R. Huber, Olaf Ortmann, Elisabeth C. Inwald in Der Gynäkologe
    Article 03 November 2020
Did you find what you were looking for? Share feedback.